Skip to main content
. 2019 Oct 15;191(41):E1128–E1135. doi: 10.1503/cmaj.190047

Figure 3:

Figure 3:

Substantial loss of kidney function, ESKD or death from kidney disease. Substantial loss of kidney function was defined as doubling of serum creatinine level in the CREDENCE11 and EMPA-REG OUTCOME8 trials and sustained 40% decline in estimated glomerular filtration rate in the CANVAS Program9 and DECLARE-TIMI 58 trial.10 The size of each box is weighted using the inverse variance method. Note: CI = confidence interval, ESKD = end-stage kidney disease, HR = hazard ratio, SGLT2 = sodium-glucose cotransporter-2.